• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Atropos Health Collaborates with Merck to Accelerate Real-World Evidence Generation

by Fred Pennic 01/10/2025 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know: 

– Atropos Health, a pioneer in real-world evidence (RWE) generation, announced a collaboration with Merck to leverage its innovative platform for rapid insights and analytics from real-world data (RWD). 

– The strategic partnership will enable Merck’s data science and RWE teams to conduct advanced analyses and generate publication-grade studies in less than 48 hours.

– The collaboration follows Atropos Health’s recent launch of ChatRWD™, a groundbreaking generative AI application for rapid RWE generation. In May 2024, the company also secured $33M in funding to advance its AI-driven approach to health data analysis.

Accelerating RWE for Life Savings Treatments

Merck will utilize a suite of Atropos Health’s services, including:

  • GENEVA OS™: A generative evidence acceleration operating system that facilitates rapid cohort creation and advanced analytics.
  • Green Button™: A tool that simplifies the process of asking clinical questions and generating RWE.
  • Atropos Evidence™ Network: Access to the industry’s largest federated healthcare data network, with over 300 million patient records.
  • Alexandria™: A repository of existing studies that can be rerun on local data to generate novel insights.
  • Forge™: A low-code research platform for rapid cohort creation and advanced patient studies.
  • ChatRWD™: A generative AI co-pilot that delivers full observational studies on healthcare data in minutes.

Through these tools, Merck’s teams will collaborate closely with Atropos Health’s data scientists, technologists, and researchers to accelerate evidence generation and drive faster insights.

Real-World Data at Scale

Atropos Health’s platform offers several key advantages:

  • Access to vast RWD: Provides access to a comprehensive and diverse dataset through the Atropos Evidence Network.
  • Data quality assessment: Utilizes the Real World Fitness Score to evaluate the appropriateness and quality of data for each research question.
  • Rapid evidence generation: Enables the creation of publication-grade studies in less than 48 hours.
  • AI-powered insights: Leverages AI to accelerate analysis and generate real-world evidence in minutes.

“Decisions based on RWE are becoming a reality and the speed of medicine requires quality data to be available for translation into accurate RWE rapidly.” said Dr. Brigham Hyde, CEO and co-founder at Atropos Health. “This collaboration accelerates the rate at which insights for decision making are presented and acted upon, improving the pace of innovation that ultimately improves patient care.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Virta Health CEO: GLP-1s Didn’t Kill Weight Watchers, Its Broken Model Did

Most-Read

AI Breakthrough Reveals 2025 AI Breakthrough Award Winners

AI Breakthrough Reveals 2025 AI Breakthrough Award Winners

Healthcare's Big Blind Spot: The Measurement Crisis in Inpatient Psychiatry

Healthcare’s Big Blind Spot: The Measurement Crisis in Inpatient Psychiatry

Lessons Learned from The Change Healthcare Cyberattack, One Year Later

Lessons Learned from The Change Healthcare Cyberattack, One Year Later

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Soars in NASDAQ Debut, Signaling Digital Health IPO Rebound

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |